SOP for Review of Missing Misfiled or Duplicate Submission Documents


Regulatory Affairs: SOP for Review of Missing Misfiled or Duplicate Submission Documents – V 1.0

Standard Operating Procedure for Review of Missing Misfiled or Duplicate Submission Documents

Department Regulatory Affairs
SOP No. RA/2026/778
Supersedes NA
Page No. 1 of X
Issue Date 17/04/2026
Effective Date 17/04/2026
Review Date 17/04/2028

Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a systematic and consistent framework for the identification, review, and resolution of missing, misfiled, or duplicate submission documents within regulatory affairs. This SOP supports the control objectives of ensuring data integrity, regulatory compliance, and accurate document management to maintain the quality and reliability of submission dossiers and archives.

Scope

This SOP applies to all regulatory submission documents managed by the Regulatory Affairs department, including electronic and hard copy formats. It covers documents related to regulatory filings, correspondence, dossiers, and archived records for all product types and dosage forms. This SOP excludes document management activities outside submission-related materials or non-regulatory operational records.

Responsibilities

The following roles are involved in this SOP’s execution:

  • Regulatory Affairs Executives – Executing initial document review and identification of discrepancies.
  • Regulatory Affairs Supervisors – Supervising the review process and coordinating investigations.
  • Quality Assurance (QA) – Verifying adherence to documentation control standards and providing final approval.
  • Document Control Personnel – Archiving, filing, and updating document status as per outcomes of the review.
  • Regulatory Affairs Manager – Oversight and final decision-making on non-conformities or escalations.
See also  SOP for Lifecycle Compliance Review of Marketed Products

Accountability

The Regulatory Affairs Manager is accountable for ensuring compliance with this SOP, overseeing timely implementation, coordinating training and communication, reviewing periodic effectiveness, and escalating issues as needed to quality leadership or compliance committees.

Procedure

1. Preparation and Prerequisites: Prior to initiating review activities, ensure access to the master document list, submission trackers, and archival indices. Verify that personnel conducting the review have received relevant training on documentation and regulatory standards.

2. Identification of Discrepancies: Review submitted and archived documents against submission records to detect discrepancies such as missing documents, misfiled items, or duplicates. Utilize electronic document management systems or physical file audits as applicable.

3. Preliminary Investigation: For any discrepancies detected, the Regulatory Affairs Executive shall initiate a preliminary investigation to understand the nature and cause. This may involve checking document version histories, cross-referencing filing logs, and interviewing involved personnel.

4. Classification of Findings: Categorize findings as missing documents, misfiled documents, or duplicates. Assess potential impact on submission accuracy, compliance, or regulatory timelines.

5. Corrective Actions:

  • For missing documents, attempt retrieval from originators or secondary archives. If unrecoverable, initiate documented justification and escalate according to compliance guidelines.
  • For misfiled documents, correctly re-file with updated index entries and notify stakeholders.
  • For duplicate documents, validate versions and remove or archive duplicates properly to avoid confusion.

6. Verification and Approval: Post corrective actions, the QA department shall verify the resolution, ensuring adherence to good documentation practices and confirm updates to the document control system. The Regulatory Affairs Manager shall approve closure of the issue.

7. Documentation and Record Keeping: All findings, investigations, actions taken, and approvals must be documented using the specified forms and logs listed below. Records shall be maintained in accordance with regulatory retention policies and be readily retrievable for audits.

8. Periodic Review: Conduct periodic reviews (at least annually) of the document management system to detect systemic issues or trends, recommending improvements or training needs as necessary.

See also  SOP for Global Change Implementation Tracking

9. Deviation Handling: Any deviations from this SOP or unusual discrepancies shall be documented, investigated, and addressed under the deviation management system, with escalation to Quality and Compliance teams.

10. Safety and Compliance Checks: Throughout, ensure adherence to GMP, internal quality standards, and data integrity principles while handling sensitive or confidential regulatory documents.

Abbreviations

QA – Quality Assurance
GMP – Good Manufacturing Practice
SOP – Standard Operating Procedure
RA – Regulatory Affairs
DMS – Document Management System

Documents

The following documents are required for effective implementation of this SOP:

  1. Submission Document Discrepancy Report (Annexure-1)
  2. Document Investigation and Resolution Form (Annexure-2)
  3. Corrective Action Log for Document Management (Annexure-3)

References

• ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
• EU Annex 11: Computerised Systems
• FDA 21 CFR Part 11: Electronic Records; Electronic Signatures
• PIC/S GMP Guide
• Internal Document Control and Quality Management Policies
• Regulatory Authority Guidelines on Submission Documentation and Archival

Version

1.0

Approval

Prepared By
Checked By
Approved By

Annexures

Annexure-1: Submission Document Discrepancy Report

Purpose: To formally record and communicate identified discrepancies such as missing, misfiled, or duplicate submission documents during review.

Report No. SDDR-2026-001
Date 17/04/2026
Document Title Regulatory Submission Dossier – Section 4
Type of Discrepancy Missing Document
Description of Discrepancy Module 4: Clinical Study Report page missing
Identified By Regulatory Affairs Executive
Immediate Action Taken Notified supervisor and initiated investigation
Remarks Pending retrieval from archive

Annexure-2: Document Investigation and Resolution Form

Purpose: To document the investigation findings and resolution steps taken for each identified discrepancy in submission documents.

Investigation No. INV-2026-053
Date 18/04/2026
Discrepancy Report Ref. SDDR-2026-001
Investigation Conducted By Regulatory Affairs Executive
Summary of Findings Document missing due to archive misplacement, traced to temporary storage area
Corrective Action Relocated document to master archive and updated indexing system
Preventive Action Enhanced archive tracking protocols and conducted staff retraining
Verified By QA
Date of Verification
Remarks Investigation closed and corrective actions approved
See also  SOP for CMC Change Documentation for Registered Products

Annexure-3: Corrective Action Log for Document Management

Purpose: To log and track all corrective actions implemented in response to document discrepancies within regulatory submissions.

Action No. Date Discrepancy Ref. Corrective Action Details Responsible Person Completion Date Verification Status
CA-2026-010 19/04/2026 SDDR-2026-001 Updated archive location codes and improved physical file security Document Control Officer 20/04/2026 Verified by QA
CA-2026-011 22/04/2026 SDDR-2026-001 Conducted staff refresher training on filing procedures Regulatory Affairs Supervisor 24/04/2026 Verified by QA

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
17/04/2026 1.0 Initial issue New SOP creation